Navigation Links
Luminex Corporation Vice President of Biodefense to Speak at DTRA'S 2011 CBD S&T Conference

AUSTIN, Texas, Nov. 14, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced Dr. Amy Altman, vice president of Biodefense will present at the Defense Threat Reduction Agency's (DTRA) 2011 Chemical and Biological Defense Science and Technology (CBD S&T) Conference, which takes place November 14-16, 2011 in Las Vegas, Nevada.


During the conference, Dr. Altman will present "Fully automated xMAP®-based system for the multiplex detection of biothreat agents and emerging infectious diseases" in the Novel Next Generation System Platform Technologies session. Dr. Altman's presentation will take place on Tuesday, November 15, 2011 at 9:30 a.m. at the Mirage Las Vegas, Grand Ballroom DE.

Dr. Altman joined Luminex in 2007 and was appointed vice president of Luminex's Biodefense efforts in July 2010. Leveraging her background in chemical and biological defense and technology development, Dr. Altman is charged with strategy and driving growth in the biodefense market. Dr. Altman has also served as director of the Extramural Research Office and senior director of Research and Development for the Luminex Bioscience Group. She earned her BA degree in Microbiology and her MS degree in Microbiology from Miami University and earned her Ph.D. in Molecular Biology from Vanderbilt University.

The 2011 CBD S&T Conference offers attendees the opportunity to examine the best, new, dynamic developments in basic and applied research within the chemical and biological defense landscape. Attendees will interact and collaborate with other researchers concerning the medical and physical sciences related to chemical and biological defense. Attendees will also have the opportunity to meet DTRA science and technology managers and other members of the chem-bio technologies team. For more information on the CBD S&T Conference, please visit:

About Luminex Corporation

Luminex is committed to applying its passion for innovation to advancing healthcare and research worldwide. We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP open-architecture, multi-analyte platform and our MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies that deliver cost-effective and rapid results to clinicians and researchers. Our technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies.  We are meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.  For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology please visit our website at


Harriss T. Currie
Chief Financial Officer and Vice President, Finance
Luminex Corporation

Matthew Scalo
Sr. Director, Investor Relations
Luminex Corporation

Mimi Torrington
Director, Marketing Communications
Luminex Corporation

Leslie Denson
Porter Novelli

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Reports Third Quarter 2011 Results
2. Luminex Corporation Receives Deloitte Technology Fast 500™ Award
3. Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
4. Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
5. Luminex Corporation to Present at Upcoming Investment Conferences In September
6. Luminex Corporation Reports Second Quarter 2011 Results
7. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
8. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
9. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
10. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
11. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Array BioPharma Inc. ... its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public ... through a webcast on the Array BioPharma ... --> , ...
(Date:12/1/2015)... 2015 Assurex Health, Inc. today announced ... healthcare providers an expanded range of options in ... from depression, anxiety, bipolar disorder, posttraumatic stress disorder ... i .   --> ... addition of two new drug classes, 17 FDA-approved ...
(Date:12/1/2015)... 2015 --> ... "Nucleic Acid Labeling Market by Product (Reagents & Kits, ... In Vitro Transcription, Reverse Transcription, End Labeling), by Region ... global market is expected to reach USD 1,925.7 Million ... at a CAGR of 8.65%. Browse 77 ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... Menlo Park, CA (PRWEB) , ... December 01, 2015 , ... ... Challenge (XTC) has selected 10 semi-finalists to head to Las Vegas for CES 2016, ... distinguished judges including CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific ...
(Date:12/1/2015)... China (PRWEB) , ... December 01, 2015 , ... Nurotron ... result in its largest order to date. , The order will be from ... systems. Nurotron’s Venus Cochlear Implant System is an effective solution for children and adults ...
Breaking Medicine News(10 mins):